Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope

Stefania Lombardi, Carlo Garzelli, Corinna La Rosa, +6

Journal of Virology

Linear B-cell EpitopesVitro NeutralizationImmunologyViral Structural ProteinImmunotherapy +15

Vibrio vulnificus resists phagocytosis in the absence of serum opsonins

Mark L. Tamplin, S. Specter, Gary E. Rodrick, +1

Infection and Immunity

InflammationMedical MicrobiologyBacterial InfectionsMedicineVirulence Factor +12

Dissociation between the Adjuvant vs Mitogenic Activity of a Synthetic Muramyl Dipeptide for Murine Splenocytes

S. Specter, Herman Friedman, L Chedid

Experimental Biology and Medicine

ImmunotoxicologyMicrobial PathogensImmunologyImmunodominanceCellular Pharmacology +16

Production of tumor necrosis factor (TNF-<i>alpha</i>) and lymphotoxin (TNF-<i>beta</i>) by murine pre-B and B cell lymphomas.

Reuven Laskov, Gerald Lancz, Nancy H. Ruddle, +5

The Journal of Immunology

Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted

Donatella Matteucci, Mauro Pistello, Paola Mazzetti, +7

Journal of Virology

VaccinationVeterinary VaccineFeline Immunodeficiency VirusVaccine DevelopmentAllergy +12

Suppression by Cannabinoids of a Cloned Cell Line with Natural Killer Cell Activity

Yutaka Kawakami, Thomas Klein, C. Newton, +4

Experimental Biology and Medicine

Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species

Mark L. Tamplin, S. Specter, Gary E. Rodrick, +1

Infection and Immunity

Medical MicrobiologyComplement SystemDifferential Complement ActivationPathogenic MicrobiologyHuman Complement +13

Treatment of bacterial meningitis with once daily ceftriaxone therapy

Wayne M. Dankner, James D. Connor, Mark H. Sawyer, +2

Journal of Antimicrobial Chemotherapy

Antimicrobial SusceptibilityHealth SciencesAntibioticsExtended Half-lifeDaily Ceftriaxone Therapy +10

Development of Feline Immunodeficiency Virus ORF-A (tat) Mutants: In Vitro and in Vivo Characterization

Mauro Pistello, Mila Moscardini, Paola Mazzetti, +7

Virology

Molecular VirologyHuman RetrovirusPathogenesisImmunologyVeterinary Science +7

Suppression of the Natural Killer Cell Activity of Murine Spleen Cell Cultures by Dexamethasone

William I. Cox, Nikki J. Holbrook, R. J. Grasso, +2

Experimental Biology and Medicine

InflammationAllergyNk ActivityMedicineGranulocyte +12